Darwin Global Management »

Dianthus Therapeutics shares owned by Darwin Global Management

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Darwin Global Management from 13F filings

Historical chart of Darwin Global Management investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Darwin Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Darwin Global Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.5M 17k 83.92

More positions owned by Darwin Global Management

Insmed Com Par $.01 (INSM)
Belite Bio Sponsored Ads (BLTE)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Roivant Sciences SHS (ROIV)
Dianthus Therapeutics (DNTH)

View all positions for Darwin Global Management

Top funds holding Dianthus Therapeutics

FMR
BlackRock
RA Capital Management
Fairmount Funds Management
Wellington Management Company
Avidity Partners Management
Vanguard Group
Vanguard Capital Management
Octagon Capital Advisors
TCG Crossover Management
Citadel Advisors
State Street Corporation
VR Adviser
Fred Alger Management
Deerfield Management Company

View all funds holding Dianthus Therapeutics